Primary central nervous system lymphomas: A 30-year experience at a single institution

被引:0
|
作者
Nuckols, JD
Liu, K
Burchette, JL
McLendon, RE
Traweek, ST
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[2] Austin Pathol Associates, Austin, TX USA
关键词
AIDS; central nervous system; lymphoma; REAL classification;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary central nervous system lymphoma (PCNSL) is a rare disease that has been increasing in frequency. Clinical, histologic, and immunohistochemical data from 64 cases of PCNSL seen at Duke University Medical Center since 1968 were reviewed and tumors were classified using the REAL classification system. Thirty-two patients were male and 32 were female, with a mean age of 57.1 years, ranging from 16 to 82 years. Large B-cell lymphoma represented overwhelming the majority of PCNSL, accounting for 81% of all cases. Phenotypic T-cell lymphomas were rare with only two cases over the course of the study. Epstein-Barr virus was detected only in the immunocompromised patients and was identified in 75% of those immunocompromised patients who were tested. Overall survival was poor with a mean survival of 357 days and median survival of 158 days. One- and three-year survival rates were 29.6% and 7.8%, respectively. Type of treatment, duration of symptoms, site of lesion, and histologic subtype were not significant prognostic indicators, whereas concurrent immunosuppression was the strongest predictor of poor outcome. In AIDS patients (which accounted for 21.9% of the study group), the median survival was 65 days, which was significantly different than that seen in the immunocompetent group of 217 days (P = .001).
引用
收藏
页码:1167 / 1173
页数:7
相关论文
共 50 条
  • [21] Therapy of primary central nervous system lymphomas: A fifthteen year experience at Florence University Hospital
    Nassi, L.
    Scoccianti, S.
    Rigacci, L.
    Detti, B.
    Paganini, M.
    Bordi, L.
    Meattini, I.
    Mappa, S.
    Sulprizio, S.
    Puccini, B.
    Alterini, R.
    Cipressi, S.
    Biti, G.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 518 - 519
  • [22] Therapy of primary central nervous system lymphomas: A fifthteen year experience at florence university hospital
    Nassi, L.
    Scoccianti, S.
    Rigacci, L.
    Detti, B.
    Paganini, M.
    Bordi, L.
    Meattini, I.
    Mappa, S.
    Sulprizio, S.
    Puccini, B.
    Cipressi, S.
    Biti, G.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 187 - 187
  • [23] Central Nervous System Involvement of Rhabdomyosarcoma: A Single Institution Experience
    Moreira, Daniel C.
    Macy, Margaret E.
    Cost, Carrye R.
    Greffe, Brian S.
    Garrington, Timothy P.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (02) : 152 - 154
  • [24] Primary central nervous system lymphomas
    Batara, JF
    Grossman, SA
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (06) : 671 - 675
  • [25] Primary Central Nervous System Lymphomas
    Roth, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 736 - 736
  • [26] Primary Central Nervous System Lymphomas
    Chukwueke, Ugonma
    Grommes, Christian
    Nayak, Lakshmi
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (01) : 147 - 159
  • [27] Primary central nervous system lymphomas
    DeAngelis L.M.
    Current Treatment Options in Oncology, 2001, 2 (4) : 309 - 318
  • [28] Germ cell tumors in the central nervous system: A 16-year-single-institution experience
    Galev, G.
    Yeaney, G.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 531 - 531
  • [29] Tumors of the Central Nervous System in the First Year of Life. One Single Institution Experience
    Garcia-Ariza, M.
    Echebarria Barona, A.
    Lopez-Almaraz, R.
    Adan Pedroso, R.
    Bilbao Salcines, N.
    Ricondo De Diego, A.
    Ojinaga Nino, I.
    Galbarriatu Gutierrez, L.
    de Gopegui Ruiz, E. Ruiz
    Aurtenetxe Saez, O.
    Martin Guerrero, I.
    Zaldumbide Duenas, L.
    Navajas, A.
    Astigarraga Aguirre, I.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S462 - S462
  • [30] Definitive Radiotherapy for Head and Neck Paragangliomas - A Single-Institution 30-Year Experience
    Johnny, C.
    Huang, S. H.
    Waldron, J.
    O'Sullivan, B.
    Su, J.
    Bayley, A.
    Goldstein, D.
    Gullane, P.
    Ringash, J. G.
    Kim, J.
    Cho, J.
    Hope, A. J.
    Bratman, S. V.
    Hosni, A.
    Hahn, E.
    Tong, L.
    Xu, W.
    Caparrotti, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E292 - E293